EGFR and autosomal dominant polycystic kidney disease: To better understand the functional interaction of inhibition of AURKA and EGFR, we analyzed activation of the signaling of these drug targets and of signaling pathways relevant to ADPKD in kidney tissue collected from Pkd1−/− and wt mice after 10 weeks of drug treatment.